Recombinant Human PDE6B Protein, N-His

Introduction

Recombinant Human PDE6B Protein is a highly purified form of the human phosphodiesterase 6B enzyme, produced through recombinant DNA technology. This protein plays a crucial role in the visual transduction pathway and has been extensively studied for its structure, activity and potential applications in various diseases.

Structure

The human PDE6B gene is located on chromosome 4 and encodes for a protein of 860 amino acids. The recombinant form of this protein is produced in a host cell system, typically in E. coli or yeast, and undergoes extensive purification to ensure high quality and purity. The protein has a molecular weight of approximately 100 kDa and consists of two subunits, α and β, which are held together by disulfide bonds.

The crystal structure of recombinant human PDE6B protein has been determined, revealing its overall architecture and active site. The protein contains a catalytic domain, which is responsible for its enzymatic activity, and a regulatory domain, which helps to regulate its activity. The catalytic domain contains a conserved motif known as the GAF domain, which is involved in binding to the substrate and hydrolyzing cyclic guanosine monophosphate (cGMP).

Activity

PDE6B is a phosphodiesterase enzyme that plays a critical role in the visual transduction pathway. It is specifically expressed in the rod and cone photoreceptor cells of the retina and is responsible for the hydrolysis of cGMP, which is an important second messenger in the visual signaling cascade. This activity is essential for the termination of phototransduction and the restoration of the dark state in the retina.

Mutations in the PDE6B gene have been linked to several inherited retinal diseases, such as retinitis pigmentosa and cone-rod dystrophy, which are characterized by progressive degeneration of the photoreceptor cells. These mutations can result in a decrease or complete loss of PDE6B activity, leading to impaired visual function.

In addition to its role in the visual pathway, PDE6B has also been found to have a role in other tissues, such as the brain and heart. Studies have shown that PDE6B is involved in regulating neuronal signaling and cardiac function, highlighting its potential importance in other diseases beyond the retina.

Applications

Recombinant Human PDE6B Protein has a wide range of potential applications in both research and therapeutic settings. One of the main applications is in the study of inherited retinal diseases, as the recombinant protein can be used to understand the structure and function of PDE6B and its role in disease pathogenesis.

Furthermore, the use of recombinant PDE6B protein in drug screening and development has shown promising results. Inhibitors of PDE6B have been identified as potential therapeutic agents for inherited retinal diseases, and the use of recombinant protein in screening assays has facilitated the discovery of new drug candidates.

Lastly, recombinant PDE6B protein has also been used in gene therapy approaches for inherited retinal diseases. By delivering a functional copy of the PDE6B gene using viral vectors, it is possible to restore PDE6B activity and potentially slow down or halt the progression of the disease.

Conclusion

Recombinant Human PDE6B Protein is a highly purified form of the human phosphodiesterase 6B enzyme that has been extensively studied for its structure, activity and potential applications. Its crucial role in the visual transduction pathway and its involvement in various diseases make it a valuable tool for research and therapeutic purposes. With ongoing advancements in recombinant protein technology, the potential for PDE6B in improving our understanding and treatment of retinal diseases continues to grow.